The application of transcranial magnetic stimulation in treatment-resistant depression: insights from omics
Treatment-resistant depression (TRD) is a refractory form of major depressive disorder (MDD) for which conventional antidepressant strategies are often insufficient. Transcranial magnetic stimulation (TMS) has demonstrated clinical efficacy in TRD, but its biological mechanisms remain incompletely understood. This narrative review synthesizes current evidence across transcriptomic, epigenomic,…
Read original article on Frontiers in Psychiatry | New and Recent Articles →Related news
-
When Life Reminds You That Nothing Is Guaranteed
United States
-
Open Heart, Ungrasping Heart
United States
-
125 Happy Thanksgiving Wishes, Messages and Quotes for a Joyful Holiday
Sweden
-
Trauma and posttraumatic growth in cancer: validation of the post-traumatic stress disorder checklist for DSM-5 and the posttraumatic growth inventory-short form in patients with breast cancer
Switzerland
-
Epistemic trust, mentalizing and extremist attitudes in a German community sample
Switzerland
-
Diagnostic and predictive value of structural and high-order functional brain topology in major depressive disorder
Switzerland
-
Development and contextual adaptation of the first national clinical practice guideline for autism spectrum disorder in children and adolescents in Tunisia
Switzerland
-
Prevalence and correlates of gambling problems among forensic psychiatric patients: evidence of elevated rates from a multi-site study
Switzerland